Journal article
Tocilizumab-associated multifocal cerebral thrombotic microangiopathy
- Abstract:
-
Tocilizumab is a humanized monoclonal antibody that targets the interleukin-6 receptor (IL-6-R). It is approved for use in moderate to severe refractory rheumatoid arthritis and more recently has been found to be effective in treating neuromyelitis optica.1 Common side effects include raised hepatic transaminases, gastroenteritis, infections, and hypertension. Neurologic side effects have been described in 2 single case reports, which were confounded by the concomitant use of other antirheuma...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 374.5KB)
-
- Publisher copy:
- 10.1212/CPJ.0000000000000220
Authors
Bibliographic Details
- Publisher:
- American Academy of Neurology Publisher's website
- Journal:
- Neurology. Clinical practice Journal website
- Volume:
- 6
- Issue:
- 3
- Pages:
- e24-e26
- Publication date:
- 2016-06-27
- DOI:
- EISSN:
-
2163-0933
- ISSN:
-
2163-0402
- Pmid:
-
27347443
- Source identifiers:
-
630933
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:630933
- UUID:
-
uuid:56d64642-1b44-41bf-bed3-0fc5668648bb
- Local pid:
- pubs:630933
- Deposit date:
- 2016-12-09
Terms of use
- Copyright holder:
- American Academy of Neurology
- Copyright date:
- 2016
- Notes:
- ª 2016 American Academy of Neurology.
If you are the owner of this record, you can report an update to it here: Report update to this record